Craven House Capital (CRV) Competitors GBX 0.18 0.00 (0.00%) As of 05/30/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock CRV vs. D467, CMB, WSL, CCPE, OTT, RGO, NCA, STHP, SIHL, and AMIFShould you be buying Craven House Capital stock or one of its competitors? The main competitors of Craven House Capital include Thames Ventures VCT 2 DP67 (D467), Cambria Africa (CMB), Worldsec (WSL), CVC Credit Partners European Opportunities (CCPE), Oxford Technology 3 Venture Capital Trust (OTT), RiverFort Global Opportunities (RGO), New Century AIM VCT (NCA), Stranger (STHP), Symphony International (SIHL), and Amicorp FS (AMIF). These companies are all part of the "asset management" industry. Craven House Capital vs. Thames Ventures VCT 2 DP67 Cambria Africa Worldsec CVC Credit Partners European Opportunities Oxford Technology 3 Venture Capital Trust RiverFort Global Opportunities New Century AIM VCT Stranger Symphony International Amicorp FS Craven House Capital (LON:CRV) and Thames Ventures VCT 2 DP67 (LON:D467) are both small-cap financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership, community ranking and media sentiment. Do institutionals & insiders believe in CRV or D467? 3.3% of Craven House Capital shares are held by institutional investors. Comparatively, 0.9% of Thames Ventures VCT 2 DP67 shares are held by institutional investors. 34.3% of Craven House Capital shares are held by insiders. Comparatively, 69.6% of Thames Ventures VCT 2 DP67 shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable valuation & earnings, CRV or D467? Craven House Capital is trading at a lower price-to-earnings ratio than Thames Ventures VCT 2 DP67, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCraven House CapitalN/AN/A-£11.40K-£0.00-5,932.20Thames Ventures VCT 2 DP67N/AN/AN/A-£0.02N/A Does the media favor CRV or D467? In the previous week, Craven House Capital's average media sentiment score of 0.00 equaled Thames Ventures VCT 2 DP67'saverage media sentiment score. Company Overall Sentiment Craven House Capital Neutral Thames Ventures VCT 2 DP67 Neutral Does the MarketBeat Community believe in CRV or D467? Craven House Capital received 27 more outperform votes than Thames Ventures VCT 2 DP67 when rated by MarketBeat users. Likewise, 70.67% of users gave Craven House Capital an outperform vote while only 65.00% of users gave Thames Ventures VCT 2 DP67 an outperform vote. CompanyUnderperformOutperformCraven House CapitalOutperform Votes5370.67% Underperform Votes2229.33% Thames Ventures VCT 2 DP67Outperform Votes2665.00% Underperform Votes1435.00% Is CRV or D467 more profitable? Craven House Capital's return on equity of 0.02% beat Thames Ventures VCT 2 DP67's return on equity.Company Net Margins Return on Equity Return on Assets Craven House CapitalN/A 0.02% -3.05% Thames Ventures VCT 2 DP67 N/A N/A N/A SummaryCraven House Capital beats Thames Ventures VCT 2 DP67 on 5 of the 8 factors compared between the two stocks. Get Craven House Capital News Delivered to You Automatically Sign up to receive the latest news and ratings for CRV and its competitors with MarketBeat's FREE daily newsletter. Email Address CRV vs. The Competition Export to ExcelMetricCraven House CapitalAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£676,000.00£1.20B£5.76B£2.92BDividend Yield2.57%4.41%4.17%4.84%P/E Ratio-5,932.2020.9712.91127.90Price / SalesN/A2,417.161,734.98273,121.27Price / Cash1.4060.6349.8328.29Price / Book-0.011.151.353.85Net Income-£11,399.98£264.00M£1.14B£5.93B7 Day Performance-12.50%0.98%0.57%1.42%1 Month Performance16.67%15.96%9.15%15.86%1 Year PerformanceN/A3.40%13.49%30.76% Craven House Capital Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVCraven House CapitalN/AGBX 0.18flatN/AN/A£676,000.00N/A-5,932.203D467Thames Ventures VCT 2 DP67N/AN/AN/AN/A£2.69MN/A-1,200.00N/AGap DownCMBCambria AfricaN/AN/AN/AN/A£2.45M£1.41M-3.759WSLWorldsecN/AGBX 2.25flatN/AN/A£2.40M£-270,215.86-2.98N/ACCPECVC Credit Partners European OpportunitiesN/AN/AN/AN/A£2.13MN/A0.00N/AGap DownOTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M£-85,000.00-12.59203Gap DownRGORiverFort Global OpportunitiesN/AN/AN/AN/A£2.09M£433,482.003.1711,900Gap DownNCANew Century AIM VCTN/AN/AN/AN/A£2.00M£-2,760,000.00-68.92N/ASTHPStrangerN/AN/AN/AN/A£2.00MN/A0.00N/ASIHLSymphony InternationalN/AGBX 0.39+4.0%N/A+4.0%£2.00M£12.28M-1.95N/AGap UpAMIFAmicorp FSN/AGBX 1.60flatN/AN/A£1.92M£14.47M3.27108 Related Companies and Tools Related Companies Thames Ventures VCT 2 DP67 Alternatives Cambria Africa Alternatives Worldsec Alternatives CVC Credit Partners European Opportunities Alternatives Oxford Technology 3 Venture Capital Trust Alternatives RiverFort Global Opportunities Alternatives New Century AIM VCT Alternatives Stranger Alternatives Symphony International Alternatives Amicorp FS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRV) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredMidnight trade alert: After-hours spike incoming??? Most traders don’t realize this… But the closing bell means jack $#!&. They hear the bell and they think...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Craven House Capital Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Craven House Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.